CN116870076B - Anti-inflammatory analgesic traditional Chinese medicine composition and preparation method and application thereof - Google Patents

Anti-inflammatory analgesic traditional Chinese medicine composition and preparation method and application thereof Download PDF

Info

Publication number
CN116870076B
CN116870076B CN202311081342.6A CN202311081342A CN116870076B CN 116870076 B CN116870076 B CN 116870076B CN 202311081342 A CN202311081342 A CN 202311081342A CN 116870076 B CN116870076 B CN 116870076B
Authority
CN
China
Prior art keywords
herba
inflammatory
traditional chinese
chinese medicine
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202311081342.6A
Other languages
Chinese (zh)
Other versions
CN116870076A (en
Inventor
何希瑞
杨燕
刘玉洁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhuhai Campus Of Zunyi Medical University
Original Assignee
Zhuhai Campus Of Zunyi Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhuhai Campus Of Zunyi Medical University filed Critical Zhuhai Campus Of Zunyi Medical University
Priority to CN202311081342.6A priority Critical patent/CN116870076B/en
Publication of CN116870076A publication Critical patent/CN116870076A/en
Application granted granted Critical
Publication of CN116870076B publication Critical patent/CN116870076B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288Taraxacum (dandelion)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/86Violaceae (Violet family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The application discloses an anti-inflammatory and analgesic traditional Chinese medicine composition in the technical field of traditional Chinese medicine compositions, which comprises the following components in percentage by mass: 25-35% of Japanese apricot, 10-20% of dandelion, 10-20% of viola yedoensis, 5-15% of safflower, 5-10% of angelica, 5-10% of szechuan lovage rhizome, 2-10% of prepared rehmannia root, 2-10% of centella asiatica and 1-3% of natural borneol. The scheme combines 9 traditional Chinese medicinal materials such as the herba schizophragmatis integrifolii radicis, the dandelion, the herba violae and the like, has proper compatibility of the components, synergistic effect, and has good effects of detumescence, analgesia, blood circulation promoting, blood stasis removing, anti-inflammatory, bacteriostasis and small toxic and side effects.

Description

Anti-inflammatory analgesic traditional Chinese medicine composition and preparation method and application thereof
Technical Field
The invention relates to the technical field of traditional Chinese medicine compositions, in particular to an anti-inflammatory and analgesic traditional Chinese medicine composition, and a preparation method and application thereof.
Background
Chronic pain (Chronic pain) is a common Chronic disease that may be caused by a variety of causes, including tissue injury, chronic disease, psychological factors, and the like, affecting more than 30% of people worldwide. Chronic pain is different from acute pain, is a pain state which exists for a long time (generally more than 3 months), has persistent pain sensation and different degrees of pain, and has obvious influence on the psychological, emotional and life quality of patients. According to statistics, the population of chronic pain in China exceeds 3 hundred million people, and along with aging of the population and aggravation of the chronic pain, the incidence rate of the chronic pain is increased year by year, so that economic burden and medical resource pressure are brought to society. Therefore, how to effectively improve pain and improve the life quality of patients becomes a hot problem of the current research.
Currently, the main means for treating chronic pain include western medicine treatment and traditional Chinese medicine treatment. Western medicine has obvious advantages in the treatment of chronic pain, but toxic and side effects, adverse reactions, risks and drug resistance of the western medicine cannot be ignored. The traditional Chinese medicine accumulates thousands of years of medication history in the aspect of treating chronic pain, has unique curative effect and relatively small adverse reaction, and has great clinical value by deeply digging a traditional Chinese medicine compound for treating pain. In particular, with the improvement of the status of traditional Chinese medicine and the gradual prominence of the limitations of western medicine treatment, the traditional Chinese medicine has become a trend for treating chronic pain.
The invention provides an anti-inflammatory and analgesic traditional Chinese medicine composition, a preparation method and application thereof, and the traditional Chinese medicine composition is prepared by firstly mixing traditional Chinese medicines such as herba hyperici japonici, dandelion, herba violae and the like, has good effects of detumescence and acesodyne, promoting blood circulation and removing blood stasis, resisting inflammation and bacteriostasis and small toxic and side effects, and provides an effective scheme for treating chronic pain.
Disclosure of Invention
The invention aims to provide an anti-inflammatory and analgesic traditional Chinese medicine composition, a preparation method and application thereof, and the traditional Chinese medicine composition is prepared from the traditional Chinese medicines of herba schizophragmatis integrifolii radicis, dandelion, herba violae and the like, has proper compatibility and synergistic effect of the components, and has the good effects of detumescence and analgesia, blood circulation promoting and stasis removing, anti-inflammatory and bacteriostasis and small toxic and side effects.
In order to achieve the above purpose, the present invention provides the following technical solutions:
an anti-inflammatory and analgesic traditional Chinese medicine composition comprises the following components in percentage by mass: 25-35% of Japanese apricot, 10-20% of dandelion, 10-20% of viola yedoensis, 5-15% of safflower, 5-10% of angelica, 5-10% of szechuan lovage rhizome, 2-10% of prepared rehmannia root, 2-10% of centella asiatica and 1-3% of natural borneol.
Further, the composition comprises the following components in percentage by mass: 27% of Japanese apricot, 15% of dandelion, 15% of viola philippica, 10% of centella asiatica, 10% of safflower, 8% of Chinese angelica, 8% of ligusticum wallichii, 5% of prepared rehmannia root and 2% of natural borneol.
Further, the composition comprises the following components in percentage by mass: 30% of herba schizophragmatis integrifolii radicis, 15% of dandelion, 15% of herba violae, 10% of safflower, 8% of angelica sinensis, 8% of ligusticum wallichii, 7% of prepared rehmannia root, 5% of centella asiatica and 2% of natural borneol.
Further, the composition comprises the following components in percentage by mass: 35% of herba schizophragmatis integrifolii radicis, 20% of dandelion, 20% of herba violae, 5% of safflower, 5% of angelica sinensis, 5% of ligusticum wallichii, 5% of prepared rehmannia root, 4% of centella asiatica and 1% of natural borneol.
A preparation method of an anti-inflammatory analgesic traditional Chinese medicine composition comprises the following steps:
a. selecting materials: selecting herba Hyperici Japonici, herba Taraxaci, herba Violae, carthami flos, radix Angelicae sinensis, rhizoma Ligustici Chuanxiong, radix rehmanniae Preparata, herba Centellae, and natural Borneolum Syntheticum;
b. alcohol extraction: ethanol is used for respectively carrying out ethanol extraction on the herba delphinii, the angelica sinensis, the centella asiatica, the dandelion, the viola philippica and the safflower to obtain an extracting solution, and all extracting solutions are combined to obtain an ethanol extracting solution;
c. water extraction: extracting rhizoma Ligustici Chuanxiong and radix rehmanniae Preparata with water respectively to obtain extractive solutions, and mixing all extractive solutions to obtain water extractive solution;
d. preparing paste: mixing the ethanol extractive solution and the water extractive solution, adding Borneolum Syntheticum, heating, concentrating to obtain extract, and making into Chinese medicinal composition.
Further, the concentration of ethanol in the step b when the herba hyperici japonici, the angelica sinensis, the centella asiatica, the dandelion, the viola philippica and the safflower are subjected to alcohol extraction is respectively as follows: 70-75%, 60-70%, 50-60%, 40-50%; soaking herba Gei, radix Angelicae sinensis, herba Centellae, herba Taraxaci, herba Violae and Carthami flos in ethanol, and reflux-extracting for 2-3 hr, 1-2 hr, and 20-30 min; mixing the extractive solutions, and vacuum filtering to obtain ethanol extractive solution.
And c, soaking the ligusticum wallichii and the prepared rehmannia root in distilled water, heating and reflux-extracting for 3-5 times, combining all the extracting solutions, and carrying out suction filtration to obtain a water extracting solution.
A Chinese medicinal preparation comprises a Chinese medicinal composition and pharmaceutically acceptable adjuvants.
Further, the dosage forms of the traditional Chinese medicine preparation comprise external preparations and oral preparations, wherein the external preparations comprise patches, ointments or creams, and the oral preparations comprise granules, tablets, capsules, oral liquid, medicinal granules or pills.
An application of an anti-inflammatory and analgesic Chinese medicinal composition in preparing medicines for clearing heat and detoxicating, promoting blood circulation for removing blood stasis, detumescence and relieving pain, and resisting inflammation and inhibiting bacteria is provided.
The working principle and the beneficial effects of the invention are as follows: the composition has the effects of clearing heat and detoxicating, and relieving swelling and pain, and is often used for treating traumatic injury, sore throat, toothache, carbuncle swelling and muscle, pyocutaneous disease swelling and tonsillitis, pharyngolaryngitis, stomatitis, acute conjunctivitis and other diseases. The herba Hyperici Japonici contains active ingredients such as plum folic acid, herba Hyperici Japonici Mei Dusu and flavonoids, and has antibacterial, antiinflammatory, antioxidant and bone wound healing promoting effects.
Dandelion has effects of clearing heat and detoxicating, detumescence and resolving hard mass, and is often used for treating furuncle sore, stranguria due to heat, venomous snake bite, jaundice, damp-heat disease, acute conjunctivitis, etc. The modern medical research shows that the main active ingredients of dandelion comprise various functional ingredients such as flavonoid, triterpenes, sesquiterpenes, sterols, polysaccharides, organic acids, volatile oils and the like, and the dandelion has good biological activities of resisting bacteria, resisting inflammation, resisting oxidization, protecting liver, promoting urination and the like.
Herba Violae has effects of cooling blood, relieving swelling, diminishing inflammation, and relieving pain. In traditional Chinese medicine, herba Violae is often used for treating dysmenorrhea, furuncle, snake bite, traumatic injury, etc. Modern medical research shows that the herba violae contains flavonoid, volatile oil, phytosterol and other active ingredients, and has the effects of resisting inflammation, easing pain, resisting bacteria and resisting oxidation.
Safflower has the effects of activating blood, dredging channels, dispersing blood stasis and relieving pain, and has the effects of nourishing blood, activating blood and removing blood stasis with angelica, ligusticum wallichii and the like. Can be used for treating shoulder pain, arm pain, lumbago, leg pain, or pain of whole body due to obstruction of channels by qi and blood. In modern medical research, safflower contains chemical components such as flavone, alkaloid, polyacetylene, spermidine, lignan, sterol, polysaccharide and the like, and has biological activities such as dilating blood vessels, improving microcirculation, diminishing inflammation, easing pain, enhancing immune function and the like.
Dang Gui has the actions of regulating and replenishing blood, and is often used for replenishing blood, activating blood and traumatic injury. It mainly contains volatile oil, organic acid, amino acid, flavonoid, polysaccharide and other chemical components, and has the pharmacological effects of resisting inflammation, promoting hematopoiesis, protecting liver and kidney, enhancing immunity, regulating cardiac and cerebral blood vessels and the like.
Chuan Xiong is often used for treating wind-cold headache, dizziness, hypochondriac pain, abdominal pain, cold arthralgia, tendons contracture, abdominal pain, chest hypochondrium stabbing pain, traumatic injury, headache, rheumatalgia, etc. The chemical components of the ligusticum wallichii mainly comprise phthalide and dimers, alkaloids, organic acid phenol, polysaccharide and cerebroside and ceramide compounds thereof, and the ligusticum wallichii has pharmacological effects of easing pain, resisting inflammation, resisting oxidation, resisting coagulation, protecting cells and the like.
Prepared rehmannia root, radix rehmanniae Preparata has the effects of nourishing yin and blood, replenishing vital essence and marrow, and is clinically used for treating liver-kidney yin deficiency, soreness and weakness of waist and knees, bone steaming and hectic fever and the like. The prepared rehmannia root contains chemical components such as iridoid glycoside, phenethyl alcohol glycoside, ionone, amino acid, polysaccharide and the like, and has the biological activities of enhancing immunity, improving cardiovascular system, resisting inflammation, resisting fatigue and the like.
Centella asiatica has the effects of clearing heat and promoting diuresis, removing toxicity and relieving swelling, and activating blood and relieving pain, and is clinically used for treating carbuncle, sore and swelling, traumatic injury, sore throat, liver and gall stones and other diseases. Mainly contains chemical components such as triterpenoid saponins, flavonoids, volatile oils, polyacetylene olefins and the like, and has the biological activities of promoting wound healing, inhibiting scar hyperplasia, relieving arthritis, improving kidney and lung injury and the like.
Natural borneol has the advantages of fragrance, channeling, clearing heat and relieving pain, and is widely used for treating various sores and ulcers. In modern medical research, borneol has the pharmacological actions of resisting inflammation, relieving pain, resisting myocardial ischemia and the like.
The composition is prepared from the common lantana leaf, which has the functions of clearing heat and detoxicating, and relieving swelling and pain, and is used as a monarch drug; dandelion, herba violae and centella asiatica have the effects of relieving swelling and resolving masses, clearing heat and promoting diuresis, and are ministerial drugs; safflower and angelica, activating blood circulation to dissipate blood stasis; ligusticum wallichii and prepared rehmannia root have the effects of activating blood and promoting qi circulation, dispelling wind and relieving pain, and all the medicines are adjuvant medicines; borneol is used for guiding the medicine upwards, inducing resuscitation and refreshing the mind. The whole formula has the functions of clearing away heat and toxic materials, promoting blood circulation, removing obstruction in collaterals, and relieving swelling and pain.
The invention provides a traditional Chinese medicine composition containing 9 traditional Chinese medicines such as herba schizophragmatis integrifolii radicis, dandelion, herba violae and the like, and a preparation prepared from the traditional Chinese medicine composition can be used for resisting inflammation and easing pain and can be used for treating chronic pain such as neck, shoulder, waist and leg pain, sprain, muscle strain, nerve pain, joint pain, musculoskeletal pain, fibromyalgia, osteoporosis, cancer pain, postoperative pain after trauma, scapulohumeral periarthritis, lumbar disc herniation, tennis elbow, myofascitis, arthritis and the like.
Based on the compatibility theory of traditional Chinese medicines, the composition takes the herba schizophragmatis integrifolii radicis as a main medicine and takes Chinese medicinal materials such as the herba violae, the dandelion, the safflower and the like as auxiliary medicines so as to achieve the effects of strengthening anti-inflammatory and analgesic effects and reducing toxic and side effects, and has the effects of treating various chronic pains such as rheumatalgia, muscle pain of bones and muscles, traumatic blood stasis and pain, joint swelling pain, neuralgia, waist, knee and the like.
The composition is prepared into clinically acceptable unused preparation types by adding auxiliary materials according to a conventional process, wherein the gel emplastrum is prepared from an extract mixture mainly comprising the herba schizophragmatis integrifolii radicis, the herba violae and the dandelion, and pharmacological experiment results show that the gel emplastrum has good anti-inflammatory and analgesic effects, so that the gel emplastrum has the beneficial effects of treating chronic pain.
Detailed Description
The following is a further detailed description of the embodiments:
the proportions of the medicinal materials of examples 1 to 3 and comparative examples 1 to 2 are shown in Table 1 below:
TABLE 1 medicinal material proportioning table
Examples 1 to 3 and comparative examples 1 to 2 were identical in terms of the preparation method except for differences in the raw materials and the proportions thereof, and the specific preparation process was as follows:
the Chinese medicinal composition shown in the embodiment 1 is prepared into the compound Dimei oral liquid-1
The stock was prepared as shown in example 1 of table 1: 300 g of local plum, 150 g of dandelion, 150 g of viola philippica, 100 g of safflower, 80 g of angelica, 80 g of ligusticum wallichii, 70 g of prepared rehmannia root, 50 g of centella asiatica and 20g of natural borneol.
The preparation method of the compound Dimei oral liquid-1 comprises the following steps:
(1) Selecting materials: 300 g of local plum, 150 g of dandelion, 150 g of viola yedoensis, 100 g of safflower, 80 g of angelica, 80 g of ligusticum wallichii, 70 g of prepared rehmannia root, 50 g of centella asiatica and 20g of natural borneol;
(2) Alcohol extraction: respectively taking 75%, 70%, 60% and 50% ethanol solution as extracting solutions, soaking herba Gei, radix Angelicae sinensis, herba Centellae, herba Taraxaci, herba Violae and Carthami flos, and performing reflux extraction for 3h, wherein reflux extraction time of herba Gei, herba Taraxaci and herba Violae is 3h, radix Angelicae sinensis and herba Centellae is 1h, carthami flos is 20min, mixing the extracting solutions, and performing suction filtration to obtain ethanol extracting solution;
(3) Water extraction: soaking rhizoma Ligustici Chuanxiong and radix rehmanniae Preparata in distilled water, reflux extracting for 3 times, mixing the extractive solutions, and vacuum filtering to obtain water extractive solution;
(4) Preparation: mixing the ethanol extractive solution obtained in step (2) with the water extractive solution obtained in step (3), adding natural Borneolum Syntheticum at a certain proportion, mixing, heating under reduced pressure to recover ethanol, concentrating, refrigerating at 5deg.C for 24 hr, and filtering to obtain medicinal liquid (compound Di Mei oral liquid-1).
The Chinese medicinal composition shown in the embodiment 2 is prepared into the compound Dimei oral liquid-2
The stock was prepared as shown in example 2 of table 1: 270 g of local plum, 150 g of dandelion, 150 g of viola yedoensis, 100 g of centella asiatica, 100 g of safflower, 80 g of angelica sinensis, 80 g of ligusticum wallichii, 50 g of prepared rehmannia root and 20g of natural borneol.
The preparation method of the compound Dimei oral liquid-2 comprises the following steps:
(1) Selecting materials: 270 g of local plum, 150 g of dandelion, 150 g of viola yedoensis, 100 g of centella asiatica, 100 g of safflower, 80 g of angelica sinensis, 80 g of ligusticum wallichii, 50 g of prepared rehmannia root and 20g of natural borneol;
(2) Alcohol extraction: respectively taking 75%, 70%, 60% and 50% ethanol solution as extracting solutions, soaking herba Gei, radix Angelicae sinensis, herba Centellae, herba Taraxaci, herba Violae and Carthami flos, and performing reflux extraction for 3h, wherein reflux extraction time of herba Gei, herba Taraxaci and herba Violae is 3h, radix Angelicae sinensis and herba Centellae is 1h, carthami flos is 20min, mixing the extracting solutions, and performing suction filtration to obtain ethanol extracting solution;
(3) Water extraction: soaking rhizoma Ligustici Chuanxiong and radix rehmanniae Preparata in distilled water, reflux extracting for 3 times, mixing the extractive solutions, and vacuum filtering to obtain water extractive solution;
(4) Preparation: mixing the ethanol extractive solution obtained in step (2) with the water extractive solution obtained in step (3), adding natural Borneolum Syntheticum at a certain proportion, mixing, heating under reduced pressure to recover ethanol, concentrating, refrigerating at 5deg.C for 24 hr, and filtering to obtain medicinal liquid (compound Di Mei oral liquid-2).
According to the preparation method, the oral liquid is prepared from comparative example 1 and comparative example 2, namely a comparative group 1 and a comparative group 2.
The Chinese medicinal composition shown in example 3 is prepared into gel plaster
The stock was prepared as shown in example 3 of table 1: 270 g of local plum, 150 g of dandelion, 150 g of viola yedoensis, 100 g of centella asiatica, 100 g of safflower, 80 g of angelica sinensis, 80 g of ligusticum wallichii, 50 g of prepared rehmannia root and 20g of natural borneol.
The preparation method of the gel plaster comprises the following steps:
(1) Selecting materials: 270 g of local plum, 150 g of dandelion, 150 g of viola yedoensis, 100 g of centella asiatica, 100 g of safflower, 80 g of angelica sinensis, 80 g of ligusticum wallichii, 50 g of prepared rehmannia root and 20g of natural borneol;
(2) Alcohol extraction: respectively taking 75%, 70%, 60% and 50% ethanol solution as extracting solutions, soaking herba Gei, radix Angelicae sinensis, herba Centellae, herba Taraxaci, herba Violae and Carthami flos, and performing reflux extraction for 3h, wherein reflux extraction time of herba Gei, herba Taraxaci and herba Violae is 3h, radix Angelicae sinensis and herba Centellae is 1h, carthami flos is 20min, mixing the extracting solutions, and performing suction filtration to obtain ethanol extracting solution;
(3) Water extraction: soaking rhizoma Ligustici Chuanxiong and radix rehmanniae Preparata in distilled water, reflux extracting for 3 times, mixing the extractive solutions, and vacuum filtering to obtain water extractive solution;
(4) Preparing paste: mixing the ethanol extract obtained in step (2) with the water extract obtained in step (3), adding natural borneol in proportion, mixing, heating and decompressing to recover ethanol, and concentrating to obtain extract;
(5) Gel matrix preparation: sodium polyacrylate and carbomer are fully swelled in water to obtain phase A. Adding aluminum glycinate and sodium polyacrylate into glycerol, stirring to obtain phase B, and dissolving tartaric acid in small amount of water to obtain phase C. Adding the phase C into the phase A, and fully and uniformly mixing to obtain the phase D.
(6) Preparation: mixing the extract obtained in step (4) with phase D in step (5) to obtain paste, mixing with phase B in step (5), uniformly coating on backing material, covering with protective film, and sealing.
Gel plaster prescription screening experiment
1. Preparation of gel patch
Sodium polyacrylate and carbomer are fully swelled in water to obtain phase A, then aluminum glycinate and sodium polyacrylate are added into glycerin, after being stirred uniformly, phase B is obtained, tartaric acid is dissolved in a small amount of water, and phase C is obtained. Adding the phase C into the phase A, and fully and uniformly mixing to obtain the phase D. Adding the liquid medicine (extract obtained in step 4 of example 3) into phase D, mixing with phase B, coating on backing, covering with protective film, and sealing.
2. Evaluation of gel patch
The amounts of other components in the fixed matrix were unchanged, the amounts of 1 component were changed, and gel patches were prepared according to the method of item 1 above (preparation of gel patches), and the application properties, uniformity, followability and film residue of the gel patches were examined with sensory evaluation as evaluation indexes, and the optimal amounts of each factor were selected.
Through a single factor test, the optimal matrix prescription is selected by taking the dosage of sodium carboxymethylcellulose (CMC-Na), tartaric acid, sodium polyacrylate and dihydroxyaluminum as factors. The sensory evaluation scoring criteria of the screening prescription are shown in Table 2, and the sensory evaluation results of the various gel matrices at different dosages are shown in Table 3.
TABLE 2 sensory evaluation scoring criteria
TABLE 3 sensory evaluation of various gel matrices at different levels
According to the method of item 1, various gel matrixes with different dosages are screened, and the results are shown in table 3, and the optimal matrix dosage of the gel plaster can be screened through the evaluation total score of a single factor experiment, wherein the optimal matrix dosage is as follows: the dosage of sodium polyacrylate is 2.00g, the dosage of sodium carboxymethylcellulose is 0.06g, the dosage of aluminum glycyrrhizate is 0.20g, and the dosage of tartaric acid is 0.05g.
Pharmacodynamic effects
(1) Influence of compound Dimei oral liquid on glacial acetic acid induced mouse torsion reaction
42 male mice of Kunming species, with a weight of 18-22 g. The dosage of each mouse is determined according to the body weight, the experimental mice are randomly divided into 7 groups which are respectively a model control group (physiological saline 0.2ml/10 g), a compound Di Mei oral liquid-1 low dose group (10 ml/kg), a compound Di Mei oral liquid-1 high dose group (20 ml/kg), a compound Di Mei oral liquid-2 low dose group (10 ml/kg), a compound Di Mei oral liquid-2 high dose group (20 ml/kg), a comparison 1 group and a comparison 2 group respectively irrigate the stomach with the traditional Chinese medicine oral liquid prepared by the comparison example 1 and the comparison example 2. The stomach was irrigated continuously for 7d, once daily. After the last administration for 1h, each group of mice was respectively injected with 0.2ml/10g of 0.6% acetic acid solution (prepared before the acetic acid solution is used), and the number of times of torsion reaction (abdominal contraction indent and extension hindlimb) of each group within 15min after the acetic acid solution injection was observed and recorded. And (3) calculating the inhibition rate of torsion reaction: percent inhibition (%) = (average number of twists of model control group-average number of twists of administration group)/average number of twists of model control group x 100%, experimental results are shown in table 4.
Table 4-influence of compound Dimei oral liquid on glacial acetic acid induced mouse torsion reaction (n=6)
Note that: in comparison with the set of models, * P<0.001, *** p < 0.001, a represents, compared with the comparative group 1 * P is less than 0.05. As can be seen from the experimental results in Table 4, compared with the model control group, the compound Dimei oral liquid can remarkably reduce the number of times of twisting the mice caused by acetic acid, and shows remarkable analgesic activity (P < 0.001).
(2) Influence of Compound Di Mei Ning adhesive plaster on glacial acetic acid induced mouse torsion reaction
18 male mice are selected, the weight of the male mice is 18-22 g, and the male mice are randomly divided into 3 groups: blank, positive drug group (flurbiprofen gel patch) 40mg/kg, compound Di Mei Ning gel patch group (40 mg/kg,100 mg/kg). The mice were dehaired on their abdomen 1d prior to the experiment, with a range of about 2cm x 2cm size, with no skin nicks, lesions. The animals of each group were given by external application to the skin or by external application according to the designed group and dose in the morning of the next day, and then fixed with a non-irritating adhesive tape. The medicine is changed 1 time a day, and the medicine is continuously administrated for 7d. 30min after the last administration, 0.1ml/10g of glacial acetic acid with the concentration of 0.6% is injected into the abdominal cavity, the number of times of twisting the mice in 20min after the inflammation is recorded, and the inhibition rate is obtained, wherein the inhibition rate (%) = [ (number of twisting the model control group-number of twisting the administration group)/number of twisting the model control group ] x 100%. The experimental results are shown in Table 5.
Table 5 influence of compound Di Mei Ning adhesive plaster on the number of times of twisting mice by glacial acetic acid (n=6)
Note that: in comparison with the set of models, *** P<0.001;
the results in table 5 show that compared with the blank matrix control group, the compound spot plum gel paste has 74.05% of inhibition rate on the torsion of mice caused by glacial acetic acid and 84.86% of inhibition rate on the positive drug group, and the compound spot plum gel paste has good analgesic effect on the pain of mice caused by glacial acetic acid.
(3) Influence of compound Dimei oral liquid on rat foot swelling caused by complete Freund adjuvant
SD rats are randomly divided into a control group, a model group and a compound Japanese apricot oral liquid-1 low-dose and high-dose groups (10 ml/kg and 20 ml/kg) according to the body weight, wherein each group comprises 6 Japanese apricot oral liquids. 100 μl of Complete Freund's Adjuvant (CFA) was subcutaneously injected into the plantar portion of the hind foot, and an equivalent amount of physiological saline was administered to the model control group. The intragastric administration was started on the same day, 14d was continued, and the post-lateral toe volume of the mice was measured at the same time point before the start of administration (T0) and after the administration (T7) and 14 (T14) d. The change in volume of the plantar region of the rat foot before and after the inflammation of each group of rats was calculated, and the anti-inflammatory effect of the drug was expressed as the degree of plantar swelling. Plantar swelling = plantar volume post-dose-plantar volume pre-dose.
Studies have shown that the experimental rats had significant reddening of their feet 48 hours after CFA administration. Both model and drug groups significantly increased toe volume after CFA administration compared to the normal control group (table 6); compared with the model group, the compound plum oral liquid with 7 th and 14d of continuous administration can obviously inhibit the swelling degree of the feet of rats and shows obvious anti-inflammatory activity. The experimental results are shown in Table 6.
TABLE 6 Effect of Compound Dimei oral liquid on CFA-induced rat foot swelling
Note that: in comparison with the set of models, * P<0.05, ** p is less than 0.01; in comparison with the normal control group, ### P<0.001。
(4) Influence of compound Dimei gel plaster on rat foot swelling caused by CFA
SD rats were randomly divided into normal control group, model control group (blank matrix gel paste), positive drug group (flurbiprofen gel paste) and compound spot Mei Ning gel paste group, 6 each. CFA 100 μl was subcutaneously injected into the plantar portion of the hind foot, and rats in the model control group were given an equivalent amount of physiological saline. Dosing was started on the same day, with continuous application of dosing for 14d, and the lateral hind toe volumes of mice were measured at the same time point before dosing (T0) and after dosing for 7 and 14 d. The change in volume of the plantar region of the rat foot before and after the inflammation of each group of rats was calculated, and the anti-inflammatory effect of the drug was expressed as the degree of plantar swelling. Plantar swelling = plantar volume post-dose-plantar volume pre-dose.
The foot volume of the rats was significantly increased after CFA administration compared to before molding. The model control and drug groups showed a significant increase in toe volume after CFA administration (table 7) compared to the normal control, and the continuously administered 7 th and 14 th days, the compound dot-matrix plum gel patch was similar to the flurbiprofen gel patch compared to the model group, which significantly reduced the swelling degree of the rat feet, showing a significant anti-inflammatory effect. CFA is widely used to induce chronic inflammatory pain models that can cause local peri-tissue inflammation and pain responses, such as foot skin and ankle pain, and the like. Based on the beneficial effects of the compound Di Mei Ning adhesive plaster on the model, the compound Di Mei Ning adhesive plaster can be used for treating related diseases such as inflammation, inflammatory pain and the like. The experimental results are shown in Table 7.
TABLE 7 Effect of Compound Dimei gel plaster on CFA-induced rat foot swelling
Note that: in comparison with the control group of the model, *** p is less than 0.001; in comparison with the normal control group, ### P<0.001。
the invention is illustrated by the above embodiments as a Chinese medicinal composition for treating traumatic injury, swelling and pain due to blood stasis, neuralgia, arthritis and other chronic pains, and its preparation method and application, but the invention is not limited to the above embodiments, i.e. it is not meant that the invention must be practiced by the above embodiments. It should be apparent to those skilled in the art that any modification of the present invention, equivalent substitution of raw materials for the product of the present invention, addition of auxiliary components, selection of specific modes, etc., falls within the scope of the present invention and the scope of disclosure.

Claims (10)

1. The anti-inflammatory and analgesic traditional Chinese medicine composition is characterized by comprising the following components in percentage by mass: 25-35% of Japanese apricot, 10-20% of dandelion, 10-20% of viola yedoensis, 5-15% of safflower, 5-10% of angelica, 5-10% of szechuan lovage rhizome, 2-10% of prepared rehmannia root, 2-10% of centella asiatica and 1-3% of natural borneol.
2. The anti-inflammatory and analgesic traditional Chinese medicine composition according to claim 1, is characterized by comprising the following components in percentage by mass: 27% of Japanese apricot, 15% of dandelion, 15% of viola philippica, 10% of centella asiatica, 10% of safflower, 8% of Chinese angelica, 8% of ligusticum wallichii, 5% of prepared rehmannia root and 2% of natural borneol.
3. The anti-inflammatory and analgesic traditional Chinese medicine composition according to claim 1, is characterized by comprising the following components in percentage by mass: 30% of herba schizophragmatis integrifolii radicis, 15% of dandelion, 15% of herba violae, 10% of safflower, 8% of angelica sinensis, 8% of ligusticum wallichii, 7% of prepared rehmannia root, 5% of centella asiatica and 2% of natural borneol.
4. The anti-inflammatory and analgesic traditional Chinese medicine composition according to claim 1, is characterized by comprising the following components in percentage by mass: 35% of herba schizophragmatis integrifolii radicis, 20% of dandelion, 20% of herba violae, 5% of safflower, 5% of angelica sinensis, 5% of ligusticum wallichii, 5% of prepared rehmannia root, 4% of centella asiatica and 1% of natural borneol.
5. The method for preparing an anti-inflammatory analgesic traditional Chinese medicine composition according to any one of claims 1 to 4, comprising the following steps:
a. selecting materials: selecting herba Hyperici Japonici, herba Taraxaci, herba Violae, carthami flos, radix Angelicae sinensis, rhizoma Ligustici Chuanxiong, radix rehmanniae Preparata, herba Centellae, and natural Borneolum Syntheticum;
b. alcohol extraction: ethanol is used for respectively carrying out ethanol extraction on the herba delphinii, the angelica sinensis, the centella asiatica, the dandelion, the viola philippica and the safflower to obtain an extracting solution, and all extracting solutions are combined to obtain an ethanol extracting solution;
c. water extraction: extracting rhizoma Ligustici Chuanxiong and radix rehmanniae Preparata with water respectively to obtain extractive solutions, and mixing all extractive solutions to obtain water extractive solution;
d. preparing paste: mixing the ethanol extractive solution and the water extractive solution, adding natural Borneolum Syntheticum, heating, concentrating to obtain extract, and making into Chinese medicinal composition.
6. The method for preparing an anti-inflammatory and analgesic Chinese medicinal composition according to claim 5, wherein the concentrations of ethanol in the step b are respectively as follows: 70-75%, 60-70%, 50-60%, 40-50%; soaking herba Gei, radix Angelicae sinensis, herba Centellae, herba Taraxaci, herba Violae and Carthami flos in ethanol, and reflux-extracting under heating, wherein the reflux-extracting time of herba Gei, herba Taraxaci and herba Violae is 2-3 h, the reflux-extracting time of radix Angelicae sinensis and herba Centellae is 1-2 h, and the reflux-extracting time of Carthami flos is 20-30 min; mixing the extractive solutions, and vacuum filtering to obtain ethanol extractive solution.
7. The method for preparing an anti-inflammatory and analgesic Chinese medicinal composition according to claim 6, wherein in step c, the rhizoma Chuanxiong and the radix rehmanniae Preparata are soaked in distilled water and then heated and reflux-extracted for 3-5 times, and all the extracting solutions are combined and suction-filtered to obtain the water extracting solution.
8. A Chinese medicinal preparation comprising the Chinese medicinal composition according to any one of claims 1 to 4 and pharmaceutically acceptable excipients.
9. The traditional Chinese medicine preparation according to claim 8, wherein the traditional Chinese medicine preparation is an external preparation or an oral preparation, the external preparation is a patch, an ointment or a cream, and the oral preparation is a tablet, a capsule, an oral liquid, a granule or a pill.
10. The use of an anti-inflammatory analgesic Chinese medicinal composition according to any one of claims 1 to 4 in the preparation of a medicament for clearing heat and detoxicating, promoting blood circulation by removing blood stasis, detumescence and relieving pain, and anti-inflammatory and antibacterial.
CN202311081342.6A 2023-08-25 2023-08-25 Anti-inflammatory analgesic traditional Chinese medicine composition and preparation method and application thereof Active CN116870076B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202311081342.6A CN116870076B (en) 2023-08-25 2023-08-25 Anti-inflammatory analgesic traditional Chinese medicine composition and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202311081342.6A CN116870076B (en) 2023-08-25 2023-08-25 Anti-inflammatory analgesic traditional Chinese medicine composition and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN116870076A CN116870076A (en) 2023-10-13
CN116870076B true CN116870076B (en) 2024-04-09

Family

ID=88271701

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202311081342.6A Active CN116870076B (en) 2023-08-25 2023-08-25 Anti-inflammatory analgesic traditional Chinese medicine composition and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN116870076B (en)

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050074732A (en) * 2004-01-14 2005-07-19 강명자 Crude drug composition for treating or alleviating inflammatory disease
CN101278963A (en) * 2008-05-30 2008-10-08 李念 Liquid medicament for curing bedsore
WO2009117936A1 (en) * 2008-03-25 2009-10-01 深圳力瑞医药科技有限公司 A pharmaceutical composition with effects of antipyretic, anti-inflammatory and analgesia and its preparation method
CN101933991A (en) * 2009-07-03 2011-01-05 吉林一正药业集团有限公司 Analgesic and anti-inflammatory medicament and preparation method thereof
CN103393999A (en) * 2013-08-23 2013-11-20 张凤明 Anti-inflammatory resolutive liquid medicine for promoting blood circulation to arrest pain
CN105535820A (en) * 2015-12-28 2016-05-04 内蒙古科尔沁药业有限公司 Mongolian medicine swelling subsidence ointment
CN105616356A (en) * 2014-11-07 2016-06-01 安徽中医药大学 Peach seed-safflower Siwu granule originated from peach seed-safflower Siwu decoction, and preparation method thereof
CN105998435A (en) * 2016-07-04 2016-10-12 王福宁 Miao medicine preparation for treating osteoarticular diseases and preparation method and application thereof
CN106215022A (en) * 2016-09-05 2016-12-14 佛山市顺德区宝铜金属科技有限公司 A kind of containing Herba Androsaces Umbellatae (Herba Androsaces Coccineae) sore-throat relieving Chinese medicine and preparation method
CN106214902A (en) * 2016-09-05 2016-12-14 佛山市顺德区宝铜金属科技有限公司 A kind of Chinese medicine treating acute pharyngitis
CN108478638A (en) * 2018-06-28 2018-09-04 成都春霞堂健康咨询有限公司 A kind of external application Chinese medicine extract, preparation method and its feedstock composition for dredging mammary gland
CN109106811A (en) * 2018-11-01 2019-01-01 山东省科学院生物研究所 A kind of liquid composition of antalgic and inflammation relieving and the preparation method and application thereof
CN109700992A (en) * 2019-02-27 2019-05-03 王国义 A kind of Chinese traditional treatment new method of stomatitis
KR20190101632A (en) * 2018-02-23 2019-09-02 주식회사 미싹바이오 Anti-inflammatory composition containing medicinal herbs
CN110946887A (en) * 2020-02-07 2020-04-03 山东中医药大学 Traditional Chinese medicine extract with blood-activating anti-inflammatory effect and application thereof
WO2022237842A1 (en) * 2021-05-12 2022-11-17 河北以岭医药研究院有限公司 Pharmaceutical composition for treating rheumatoid arthritis and preparation method therefor

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050074732A (en) * 2004-01-14 2005-07-19 강명자 Crude drug composition for treating or alleviating inflammatory disease
WO2009117936A1 (en) * 2008-03-25 2009-10-01 深圳力瑞医药科技有限公司 A pharmaceutical composition with effects of antipyretic, anti-inflammatory and analgesia and its preparation method
CN101278963A (en) * 2008-05-30 2008-10-08 李念 Liquid medicament for curing bedsore
CN101933991A (en) * 2009-07-03 2011-01-05 吉林一正药业集团有限公司 Analgesic and anti-inflammatory medicament and preparation method thereof
CN103393999A (en) * 2013-08-23 2013-11-20 张凤明 Anti-inflammatory resolutive liquid medicine for promoting blood circulation to arrest pain
CN105616356A (en) * 2014-11-07 2016-06-01 安徽中医药大学 Peach seed-safflower Siwu granule originated from peach seed-safflower Siwu decoction, and preparation method thereof
CN105535820A (en) * 2015-12-28 2016-05-04 内蒙古科尔沁药业有限公司 Mongolian medicine swelling subsidence ointment
CN105998435A (en) * 2016-07-04 2016-10-12 王福宁 Miao medicine preparation for treating osteoarticular diseases and preparation method and application thereof
CN106215022A (en) * 2016-09-05 2016-12-14 佛山市顺德区宝铜金属科技有限公司 A kind of containing Herba Androsaces Umbellatae (Herba Androsaces Coccineae) sore-throat relieving Chinese medicine and preparation method
CN106214902A (en) * 2016-09-05 2016-12-14 佛山市顺德区宝铜金属科技有限公司 A kind of Chinese medicine treating acute pharyngitis
KR20190101632A (en) * 2018-02-23 2019-09-02 주식회사 미싹바이오 Anti-inflammatory composition containing medicinal herbs
CN108478638A (en) * 2018-06-28 2018-09-04 成都春霞堂健康咨询有限公司 A kind of external application Chinese medicine extract, preparation method and its feedstock composition for dredging mammary gland
CN109106811A (en) * 2018-11-01 2019-01-01 山东省科学院生物研究所 A kind of liquid composition of antalgic and inflammation relieving and the preparation method and application thereof
CN109700992A (en) * 2019-02-27 2019-05-03 王国义 A kind of Chinese traditional treatment new method of stomatitis
CN110946887A (en) * 2020-02-07 2020-04-03 山东中医药大学 Traditional Chinese medicine extract with blood-activating anti-inflammatory effect and application thereof
WO2022237842A1 (en) * 2021-05-12 2022-11-17 河北以岭医药研究院有限公司 Pharmaceutical composition for treating rheumatoid arthritis and preparation method therefor

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Anti-Nociceptive and Anti-inflammatory Activities of the Ethyl Acetate Extract of Belamcanda chinensis(L.) Redoute in Raw 264.7 Cells in vitro and Mouse Model in vivo.;何希瑞,等;J Pain Res.;20220426;第1221-1232页 *
不同配比当归-川芎药对的抗炎、镇痛作用实验研究;夏青松;孔靖玮;李德顺;李思思;邓倩倩;李文飞;;湖北中医药大学学报;20151220(第06期);第1-4页 *
中药复方宫炎净的乙醇提取物抗炎作用研究;李效振;贾书红;张东升;孙跃博;朱晓庆;罗燕;李炳奇;谷新利;;石河子大学学报(自然科学版);20131215(第06期);第688-692页 *
桃红四物汤新解;丁艳杰;张前德;;黑龙江中医药;-;20100315;第-卷(第02期);第51-52页 *
点地梅合剂治疗急性扁桃体炎咽喉炎;臧浩;;江苏医药;19760629(第06期);第56页 *
点地梅治喉痹;杨文瑞;;中成药;19931227(第12期);第46页 *
甲氨蝶呤联合米非司酮配伍生化汤治疗植入性胎盘的疗效观察;罗素霞;张瑞玲;;中国社区医师(医学专业);-;20121215;第-卷(第35期);第142-143页 *
紫花地丁水提物急性毒性试验及其抗炎镇痛作用研究;李艳丽;胡彦武;;湖北农业科学;20130120(第02期);第390-392页 *

Also Published As

Publication number Publication date
CN116870076A (en) 2023-10-13

Similar Documents

Publication Publication Date Title
US6027728A (en) Herbal skin regeneration composition and method
CN103169928B (en) Externally applied traditional Chinese medicine composition for treating dysmenorrhea, as well as preparation method and application thereof
CN102228485A (en) Composition for burn rehabilitation and preparation method thereof
CN103386022A (en) Chinese medicine composition for treating tuberculous pleurisy
CN104740425A (en) Pharmaceutical composition for treating rheumatic arthralgia, preparation method and application of pharmaceutical composition
CN101310750B (en) External remedy for treating soft tissue injury and preparation method thereof
CN116870076B (en) Anti-inflammatory analgesic traditional Chinese medicine composition and preparation method and application thereof
CN103977367A (en) Traditional Chinese medicament for treating qi-stagnation blood-aggregation type bedsore and preparation method thereof
CN108495645A (en) It is applied with anti-inflammation detumescence Chinese medicinal ointment
CN1182866C (en) Medicinal liquor for curing rheumatism and traumatic injuries
CN110141622B (en) Traditional Chinese medicine composition for treating pain and preparation method and application thereof
CN116549522B (en) Application of traditional Chinese medicine composition in gout
CN116763834B (en) Traditional Chinese medicine composition and preparation for treating arthralgia as well as preparation method and application of traditional Chinese medicine composition and preparation
CN112755137B (en) Traditional Chinese medicine composition for treating mild and moderate knee osteoarthritis and application thereof
CN115120690B (en) Traditional Chinese medicine composition for treating precocious puberty and application thereof
CN112603958B (en) Traditional Chinese medicine composition for treating myofascitis and preparation method and application thereof
CN112402566B (en) Application of traditional Chinese medicine composition in preparation of medicine for treating gonarthromeningitis
CN112402565B (en) Traditional Chinese medicine composition for treating gonarthromeningitis and preparation method thereof
CN110141621B (en) Traditional Chinese medicine composition for treating pain and preparation method and application thereof
CN101112562B (en) Chinese traditional medicine composition for treating hyperosteogeny
CN115105580A (en) A topical Chinese medicinal composition containing nervonic acid for relieving swelling and pain, and its preparation method
CN104888147A (en) Traditional Chinese medicine ointment for shoulder periarthritis and preparation method thereof
CN104606444A (en) Traditional Chinese anesthesia medicine for tooth extraction and preparation method of traditional Chinese anesthesia medicine
CN117503841A (en) External traditional Chinese medicine for detumescence and acesodyne
CN111298066A (en) Traditional Chinese medicine composition of Chinese herbal essence and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant